Faeth Therapeutics FTH Cash Flow Statement (2020-2026)

NASDAQ FTH
$39.00 +2.88 (+7.97%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Faeth Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Faeth Therapeutics reported cash from operations of -$15.67M and free cash flow of -$15.67M for the quarter ended Jun 2026, down 165.2% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.25M-9.38M-13.30M-11.20M-13.44M-12.23M-10.87M-9.94M-6.89M-7.35M-8.69M-7.77M-7.25M-7.77M-7.28M-4.91M-4.57M-4.74M-170.65M-16.13M
Share-based Compensation
3.26M0.83M3.43M3.45M3.52M1.40M3.74M3.35M3.38M1.10M4.82M4.62M4.69M0.39M6.13M0.30M0.80M0.29M57.40M62.20M
Cash from Operations
-5.58M-7.87M-10.75M-11.90M-6.80M-9.57M-11.74M-9.46M-4.66M-6.16M-7.62M-5.79M-5.47M-5.79M-7.09M-5.91M-3.59M-3.86M-10.73M-15.67M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.29M0.30M0.30M0.31M0.32M0.35M0.32M0.37M0.37M0.39M0.39M0.40M0.41M0.36M0.37M0.37M0.38M0.39M
Depreciation & Amortization (CF)Depreciation & Amortization
0.14M0.33M0.16M0.14M0.15M0.16M0.16M0.14M0.14M0.16M0.14M0.14M0.14M0.19M0.03M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Accured Expenses
1.85M-2.12M2.64M-3.38M2.94M-0.18M-1.58M-0.44M0.47M-0.78M-0.70M0.33M0.48M0.55M-1.16M0.06M0.38M0.16M2.65M-2.40M
Other Working Capital Changes
-1.61M-0.27M-0.28M-0.29M-0.29M-0.31M-0.37M-0.29M-0.37M-0.37M-0.39M-0.40M-0.42M-0.42M-0.38M-0.39M-0.40M-0.41M-0.43M
Investing Activities
Capital Expenditures
0.39M0.54M0.02M0.05M0.25M0.15M0.03M0.04M0.11M0.02M0.01M
Sales of Property, Plant and Equipment
0.01M0.16M0.04M0.21M
Acquisitions
-6.46M
Change in Acquisitions & Divestments
16.00M12.37M48.50M30.50M-2.10M12.30M19.40M17.00M10.88M12.07M18.75M21.75M14.62M13.50M11.00M11.59M8.60M6.00M6.60M
Cash from Investing Activities
-0.48M5.61M12.19M13.20M8.52M16.04M2.31M19.53M8.31M8.26M5.77M6.91M12.91M-3.15M7.19M8.76M1.74M2.08M-31.44M-108.07M
Financing Activities
Other financing activities
0.03M0.24M1.03M0.10M
Change in Capital Stock
Net Shares Issued and Repurchased
1.74M0.68M1.14M0.50M0.78M1.42M2.73M0.85M0.05M2.49M
Net Equity Issued and Repurchased
0.00M200.00M
Misc.
Cash from Financing Activities
-0.01M-0.12M0.12M-0.12M-0.26M-7.95M-2.53M-0.43M-0.21M-0.18M-0.20M-0.19M-0.21M-0.17M-0.15M-0.11M185.83M-1.68M
Change in Cash
-6.07M-2.37M1.56M1.18M1.55M6.34M-9.69M2.12M1.12M1.67M-2.06M0.94M7.24M-9.14M-0.12M2.68M-2.00M-1.89M143.66M-125.42M
Free Cash Flow
-5.96M-8.40M-10.77M-11.95M-7.05M-9.57M-11.89M-9.49M-4.66M-6.16M-7.65M-5.90M-5.47M-5.79M-7.09M-5.92M-3.59M-3.86M-10.74M-15.67M
Net Cash Flow
-6.07M-2.37M1.56M1.30M1.71M6.34M-9.69M2.12M1.12M1.67M-2.06M0.94M7.24M-9.14M-0.12M2.68M-2.00M-1.89M143.66M-125.42M